EMAIL DETAILS
SUBJECT:
Re: Venture Summit | Top Innovator Nominations
PRI: NORMAL
FROM:
N
ncallahan@rosemontseneca.com
DATE:
2014-10-09 14:51:30
MSG_ID:
<CAOPXL7JuaUVMzd3ZuSyBW+RKvkyUV8-7QrTNRO0y-CmND=S2vg@mail.gmail.com>
RECIPIENTS:
TO:
H
Hunter Biden
<hbiden@rosemontseneca.com>
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
Very cool. I will try to go and think of companies we could nominate. Would you go? On Tue, Oct 7, 2014 at 10:48 AM, Hunter Biden <hbiden@rosemontseneca.com> wrote: > > > RHB > 202.333.1880 > > Begin forwarded message: > > *From:* "Joseph Cope" <jcope@ysventures.com> > *Date:* October 5, 2014 at 12:29:24 PM EDT > *To:* <hBiden@rstp.com> > *Subject:* *Venture Summit | Top Innovator Nominations* > *Reply-To:* <jcope@ysventures.com> > > Hi Hunter – > > We’re bringing together a large group of investors at the New England > Venture Summit and wanted to see if you’d like to nominate any of the > companies in your portfolio to present as one of the Top Innovators. > > Additional details about the opportunity are below. We’d also be > delighted to have you join us and the many investors already confirmed. > > Partial list of VCs and Corporate Investors already confirmed: > John Albright, Co-Founder & Managing Partner, Relay Ventures | Grant > Allen, Senior Vice President, ABB Technology Ventures | Jim Andelman, > Managing Partner, Rincon Venture Partners | Gil Beyda, Managing Partner, > Genacast Ventures | Eric Bielke, Senior Investment Associate, Siemens > Venture Capital | Sim Blaustein, Principal, BDMI Fund | David Blumberg, > Managing Partner, Blumberg Capital | Steven Chrust, Managing Director, > Centripetal Capital Partners | Daniel Chui, Manager, Verizon Ventures | > Andrew Clapp, Managing Partner, Arctaris Capital Partners | Charles Curran, > Senior Director, Qualcomm Ventures | David Donabedian, Vice President, > AbbVie Biotech Ventures | James Dugan, CEO & Managing Partner, OCA Ventures > | Imran Eba, Partner, Action Potential Venture Capital | Rami Elkhatib, > General Partner, Acero Capital | Kevin Ferro, CEO, Vatera Holdings | > Alexander Galitsky, Managing Partner, Almaz Capital Partners | Rich > Gliklich, XIR & Partner, General Catalyst Partners | Bosun Hau, Partner, > MVM Life Science Partners | Laurence Hayward, Partner, Independence Equity > | Ben Hemani, Analyst, Braemar Energy Ventures | Tetsuro Iwata, Senior > Manager, MP Healthcare Venture Management | Shamez Kanji, General Partner, > North Hill Ventures | Roman Kikta, Managing Partner, Mobility Ventures | > Carey Lai, Director, Intel Capital | Al Lauritano, Director, Technology > Licensing & Collaboration, BD Technologies | Jim Macdonald, Managing > Director, First Analysis | Ignacio Martinez, Partner, Flagship Ventures | > Vincent Miles, Partner, Abingworth | David Miller, Executive Managing > Director, Clean Energy Venture Group | Jay Onda, Principal, DoCoMo Capital > | Praveen Sahay, Managing Director, Wave Equity Partners | Akhil Saklecha, > Managing Director, Artiman Ventures | Cory Steffek, Managing Director, > Saudi Aramco Energy Ventures | Jason Tagler, Partner, Camden Partners | > Sebastian Titz, Manager, New Ventures, 3M New Ventures | Tibor Toth, > Managing Director of Investments, Massachusetts Clean Energy Center | Brent > Traidman, General Partner, Fenox Venture Capital | Kathleen Utecht, Venture > Partner, Core Innovation Capital | Geeta Vemuri, Senior Managing Director, > Baxter Ventures | Sonali Vijayavargiya, Founder & Managing Director, > Augment Ventures | David Ward, Managing Partner, MTI Ventures | Jan > Westerhues, Investment Partner, Robert Bosch Venture Capital GmbH | Keith > Witek, Corporate Vice President, Strategy and Corporate Development, AMD > Ventures | Tim Wright, General Partner, Grandbanks Capital; among many > others. > > Regards > > Joseph > > --- > The New England Venture Summit being held on December 9th-10th 2014 at > the Hilton in Boston Dedham is an annual gathering bringing together over > 500 executives for the purpose of high-level networking and deal making. > > The summit features high-level networking among investors and startups, > insightful panel sessions and presentations by cutting edge Top Innovators. > Early stage and emerging companies seeking funding have the opportunity to > attend and/or apply to present and be showcased in the Top Innovator > showcase. > The Top Innovator Showcase program is a paid presentation and demo > opportunity designed for early stage and emerging growth companies seeking > to raise visibility amongst an audience of active VCs, Corporate VCs, > Private Investors, Investment bankers, press, entrepreneurs, and corporate > development officers. A select group of more than 50 qualified early stage > and emerging growth companies seeking capital will be chosen to present on > 5 tracks including Tech, Life Sciences/Healthcare, Ed-tech, Clean-tech and > Mobile. > > Below is a link to the NEVS website, video highlights from the 2013 summit > as well as testimonials from investors and startup participants. > > To nominate a company simply email us: > > Startup #1 > Company Name: > Industry: > Founder or Other Contact: > Telephone: > Email: > Why is this company’s business model sure to succeed: > > Startup #2 > Company Name: > Industry: > Founder or Other Contact: > Telephone: > Email: > Why is this company’s business model sure to succeed: > > Startup #3 > Company Name: > Industry: > Founder or Other Contact: > Telephone: > Email: > Why is this company’s business model sure to succeed: > > Warm regards > > Joseph > > Testimonials > > > “YoungStartUps conference was a well structured and organized event with a > very high bar for qualifying ventures selected to present. This is the > major issue for VC's to consider when selected events to attend as many are > diluted with too many companies, many of which have not vetted their > concepts.” > -- Konstantine A. Drakonakis, PE // Director // LaunchCapital, LLC > > “The caliber of the companies presenting has improved every year, and is > actually at quite a nice level…. It’s also impressive that companies can > get up there and present what they’re doing in a very short period of time, > so it’s a very efficient way to hear about a lot of companies quickly, and > I think the panels are good topics; good panel members and a lot of good > issues are being addressed. So I think all the way around it’s been a good > day overall for everybody.” > -- Noah Kroloff, Managing Partner, NGN Capital > > “It’s a great venue for networking first and foremost. This conference > has introduced us to a number of people that we would never have seen > otherwise, as well as collaborations with our portfolio companies and other > portfolio companies. > So there is good energy in the air, and a very constructive environment.” > -- Dr. Douglas Lind, Managing Partner, GBP Capital > > "The quality of the feedback given to entrepreneurs by investors prior to > "showtime" was unparalleled in my experience. I highly recommend this > conference." > -- Mary Lincoln Campbell, Managing Director, EDF Ventures > > “The level and quality of folks that are real venture capitalists, manage > in private equity; Folks that are actively looking for opportunities.” > -- Wolf Shlagman, CEO, Consult a Doctor > > “I have seen about 50-60 business opportunities both in pharmaceuticals, > in Healthcare/IT and also medical devices, and I have met so many different > venture capitalists and heard their perspective, so that really is and eye > opener for me today.” > -- Iqbal Hussain, President, Meridian Laboratories > > “ I think the most impressive thing is probably the ratio of venture > capitalists to entrepreneurs. There are at least 50, if not more venture > capitalists that were walking around looking at the deals, and again I > think that’s a really nice and healthy ratio for the entrepreneurs, because > at the end of the day it’s all about them connecting with us. I would say > the quality of the presenters was very high relative to some of the > conferences both on the West coast to the Midwest, and mostly I would say > the CEOs are very well prepared and knowledgeable at what it’s going to > take to raise money, and I think that they’re prepared for the long haul to > meet and make relationships with the venture community.” > -- Mina Sooch, General partner, Apjohn Ventures > > “I thought the attendance with investors that are active was impressive, > and we had a number of good conversations. I think that in this day and age > looking for investors for whom a specific value proposition is a fit, is a > little of a needle in a haystack, and there were a few needles in the > haystack, that was good.” > -- Walter Greenblatt, Hygeia Therapeutics > > “The actual decision makers are here. And I like the fact that a lot of > companies are here, a couple west coast companies are coming here, it’s not > just the east coast. Not to mention that being able to tell your story to a > large audience and get your name out there is part of what every little > company needs. > I’m very impressed; I think we’ll definitely come back next year.” > -- Ali Tehrani, CEO, Zymeworks > > “I’m very impressed by the turnout. There’s been a lot of interest from > the VC industry, and you guys have seemed to capture a lot of the quality > firms and representatives here. You guys have done a really good job.” > -- Daniel Wood, General Partner, Mesa Verde VP > > “We currently have invested 45 million dollars, the real attitude and > feeling of this conference is much more upbeat than the last couple of > years have been in bio technology. So I’m quite impressed. > We have a lot of people that are very interested in investing, and we have > a substantial number of companies that have progressed their company in > lean times, and are now ready for further investments.” > -- David Wurzer, Managing Director, Connecticut Innovations > > “ I was impressed by the number of people here, the level of energy. You > wouldn’t think the market conditions were as tough as they are when you > walked into this room, people are more optimistic than I expected. > Quality of the deals- technology companies that I have talked to, I was > pleasantly surprised across all sectors of pharma, bio, and med-tech. some > very strong technology companies with interesting ideas that I think have a > lot of promise. We’ll definitely look at a number of business plans that we > were introduced to at the conference today.” > -- Sinclair Dunlop, Managing Partner, Rock Spring Ventures > > "There are very few venues for emerging companies to receive critical and > constructive feedback as well as an opportunity to present to the venture > capital community. In both design and execution, the Young Start-Up Summits > do just that, effectively and repeatedly. I highly recommend their forum > for both investors and emerging companies." > -- T. Forcht Dagi, M.D., Partner, HLM Venture Partners > > We look forward to reviewing your nominations and hope to see you at New > England Venture Summit! > > > > New England Venture Summit > December 9th-10th, 2014 > Hilton | Boston Dedham > http://www.youngstartup.com/newengland2014/overview.php > <http://lnk.ie/U5RN/e=hBiden@rstp.com/http://www.youngstartup.com/newengland2014/overview.php> > > Video Highlights: http://www.youngstartup.com/newengland2014/video.php > > <http://lnk.ie/U5RO/e=hBiden@rstp.com/http://www.youngstartup.com/newengland2014/video.php> > Regards, > > Joseph > > Joseph C. Cope > Venture Consultant | youngStartup Ventures > “Where Innovation Meets Capital” > > P: 212.202.1004 > f: 206.202.0225 > e: jcope@youngstartup.com > u: www.youngstartup.com > > This email was sent to hBiden@rstp.com > > -- Neil Callahan Rosemont Seneca Partners 917-945-951
METADATA:
THREAD:
INDEX:
AdhhniZQ+cpKYBvqTV+HQPnCoDVDZg==
REFERENCES:
REPLY_TO:
<520C5650-E847-46F0-81E0-A8FB66B239B6@rosemontseneca.com>
REFS:
<25e7fba175b1e21d1332c62500217dc0@ysventures.com>
<520C5650-E847-46F0-81E0-A8FB66B239B6@rosemontseneca.com>